An oft-repeated message is that primary aldosteronism is not rare; it is quite common. An equally urgent message is that ...
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
The new ACC and AHA criteria for cardiac devices emphasize more risk stratification, reflecting advances in the field in ...